Clinical Operations
Conducting Successful Site Qualification Visits using Virtual Solutions
On-site facility evaluations have historically provided us with the insight necessary to determine site performance and viability for our clinical trials. With decentralized trials as a mainstay of the current clinical research landscape, it’s imperative to leverage the virtual resources available to cultivate those same meaningful evaluations and assessments, safeguarding patient safety and data integrity.
Case Study
Rho’s Answer to Mitigating COVID-19 Risks in a Complex, Fast-Moving Pain Program
A cutting-edge biotech was running a program with three active, concurrent, pain studies across 25 sites and 218 patients, with interim database locks scheduled during the summer of 2020 and
Case Study
Successful Implementation of a Patient-Centric Decentralized Solution for an Ongoing Dermatology Clinical Trial
The COVID-19 pandemic created challenges and opportunities in the implementation of decentralized solutions. To fully realize all the advantages and benefits of a truly decentralized approach, partnering with a reliable
Considerations for Implementing Decentralized Clinical Trials
The COVID-19 pandemic has accelerated the implementation of decentralized (also referred to as virtual, remote, or hybrid) solutions for clinical trials. In addition to keeping your clinical trials on-track during the pandemic, decentralized solutions can often provide added benefits, including an improved patient experience by increasing engagement and reducing patient burden. We will discuss some considerations for successfully implementing decentralized solutions.
Key Questions for the Effective Implementation of eCOAs in your Clinical Trial
With the industry-wide push towards patient-centricity, electronic clinical outcome assessments (eCOAs) have become a more widely used strategy to streamline patient data collection, provide real-time access to data for review and monitoring, enhance patient engagement, and improve the integrity and accuracy of clinical studies. Rho answers some commonly asked questions about eCOAs.
Considerations When Starting a Vaccine Study
For over 10 years, Rho has worked in vaccine research and is currently 1 of 5 contract research organizations in the BARDA Medical Countermeasures Clinical Studies Network (MCM-CSN) that designs and conducts clinical studies needed to develop drugs, vaccines, and diagnostic tests that help protect public health. Based on our experience, we understand the risks, challenges, and solutions needed to operationalize a vaccine trial.